FIELD: chemistry.
SUBSTANCE: invention relates to a method of producing a compound of general formula (I), involving steps in accordance with the following scheme:
, where at separate steps: a) a compound of formula (IX) is converted to a compound of formula (V) in the presence of an enzyme selected from lipase B from Candida antarctica, b) the compound of formula (V), in the presence of an acid catalyst through effect of a compound which can form a protective group Z3 which is stable in alkaline medium and labile in acidic medium, is converted to a compound of formula (VIII) and c) the compound of formula (VIII) is converted to a compound of formula (II) in the presence of a nucleophilic agent; d) in the presence of a base B1, the compound of formula (II) is converted through effect of a compound of formula (VI) to a compound of formula (IIIa); e) the compound of formula (IIIa) is converted to a compound of formula (IVa), where the corresponding conversion is carried out through effect of an alcohol in the presence of an acid catalyst; f) through the effect of the compound (VII), the compound (IVa) is converted to a compound of formula (Ia) in the presence of a base B1 and g) if needed, the compound (Ia) is hydrolysed or hydrogenolysed to a compound of formula (I), if R3 denotes H; wherein the compound (IX) is a pure cis-isomer or a mixture of cis/trans-isomers, respectively; variables and substitutes assume the following values, respectively: ring A is C3-C8cycloalkyl, R1, R2, R4 and R5 independently denote , F, CI, Br, C1-C6alkyl or -O-(C1-C6alkyl); R3 denotes H, C1-C6alkyl; R6 denotes C1-C6alkyl or benzyl; X denotes C1-C6alkyl; Y denotes C1-C6alkyl; Z1 denotes a protective group which is stable in acidic medium; Z2 denotes a protective group which is stable in acidic medium; Z3 denotes a protective group which is stable in alkaline medium and labile in acidic medium; Z4 denotes a leaving group; Z5 denotes a leaving group; B1 denotes a tertiary alcoholate of an alkali-earth metal, a tertiary alcoholate of an alkali metal, an amide of an alkali-earth metal, an amide of an alkali metal, a silazide of an alkali-earth metal, a silazide of an alkali metal or a hydride of an alkali metal. The invention also relates to a method of producing a compound of general formula (I), involving steps in accordance with the following scheme:
, where at separate steps: a2) through at least one acyl group donor and in the presence of an enzyme selected from lipase B from Candida antarctica, the compound of formula (X) is converted to a compound of formula (V); steps b) - g) are described above, wherein the compound (X) is a pure cis-isomer or a mixture of cis/trans-isomers respectively. The invention also relates to a compound of general formula (IIIa), where ring A is cyclohexyl, where the X-containing and Z3-containing substitutes are in the cis-1,3-position of the cyclohexyl fragment; R1, R2 and R4 independently denote H, F, Cl, C1-C3alkyl or -C(O)-(C1-C6alkyl); Z3 denotes tetrahydropyranyl; X denotes methyl, and to a compound of general formula (VIII), where ring A is cyclohexyl, wherein the Z1-containing and Z3-containing substitutes are in the cis-1,3-position of the cyclohexyl fragment; Z1 denotes -C(O)CH3; Z3 denotes tetrahydropyranyl.
EFFECT: efficient method of obtaining the said compound.
14 cl, 5 dwg, 2 tbl, 27 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING ENANTIOMERIC FORMS OF DERIVATIVES OF 1,3-CYCLOHEXANEDIOL IN CIS ORIENTATION | 2004 |
|
RU2372319C2 |
DIARYLCYCLOALKYL DERIVATIVES, METHOD OF THEIR OBTAINING, AND APPLICATION AS PPAR-ACTIVATORS | 2002 |
|
RU2330846C2 |
METHODS OF PRODUCING AMINOCYCLOHEXYL ETHER COMPOUNDS AND INTERMEDIATE COMPOUNDS, AND METHODS FOR PRODUCTION THEREOF | 2008 |
|
RU2478617C2 |
COMPOUNDS OF SIMPLE AMINO-CYCLOHEXYLE ETHER AND METHODS OF THEIR USE | 2003 |
|
RU2330017C2 |
NOVEL CYCLIC HYDROCARBON COMPOUNDS FOR TREATMENT OF DISEASES | 2008 |
|
RU2524949C2 |
(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS | 2012 |
|
RU2668952C2 |
DERIVATIVES OF OXOPIPERIDINE, THEIR PRODUCTION AND USE IN THERAPY | 2005 |
|
RU2376298C2 |
IMIDAZOPYRAZINES AS TYROSINE KINASE INHIBITORS | 2004 |
|
RU2405784C2 |
COSMETIC COMPOSITIONS | 2005 |
|
RU2395272C2 |
POSITIVE ALLOSTERIC MODULATORS (PAM) | 2010 |
|
RU2561920C2 |
Authors
Dates
2011-03-20—Published
2005-08-23—Filed